Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Sachin Mahale"'
Autor:
Stephen J. Gray, James W. Wilson, Matthew R. Smith, Robert G. Britton, Marcos D. García, Daniel P. G. Emmerson, Sachin Mahale, Bhabatosh Chaudhuri, Paul R. Jenkins
Publikováno v:
Bioorganic & Medicinal Chemistry. 16:7728-7739
We present the design, synthesis and biological activity of a library of substituted (biphenylcarbonyl)-tryptamine and (biphenylcarbonyl)-tetrahydro-β-carboline compounds related to the natural product fascaplysin, as novel inhibitors of CDK4/cyclin
Autor:
Bhabatosh Chaudhuri, Paul R. Jenkins, Prashant Joshi, Sudhakar Manda, Sachin Mahale, Sandip B. Bharate, Ram A. Vishwakarma
Publikováno v:
Cell Death & Disease
The marine natural product fascaplysin (1) is a potent Cdk4 (cyclin-dependent kinase 4)-specific inhibitor, but is toxic to all cell types possibly because of its DNA-intercalating properties. Through the design and synthesis of numerous fascaplysin
Autor:
Bhabatosh Chaudhuri, Sonali S. Bharate, Sandip B. Bharate, Prashant Joshi, Ram A. Vishwakarma, Paul R. Jenkins, Sudhakar Manda, Sachin Mahale
Publikováno v:
Journal of medicinal chemistry. 57(22)
Biphenyl-4-carboxylic acid-[2-(1H-indol-3-yl)-ethyl]-methylamide 1 (CA224) is a nonplanar analogue of fascaplysin (2) that specifically inhibits Cdk4-cyclin D1 in vitro. Compound 1 blocks the growth of cancer cells at G0/G1 phase of the cell cycle. I
Autor:
A. James Wilson, Bhabatosh Chaudhuri, Yu Yam Chan, Daniel P. G. Emmerson, Marcos D. García, Sachin Mahale, Emma J. Murphy, Paul R. Jenkins, Michael P. Dickens, Carine Aubry
We present the design, synthesis and biological activity of a new series of substituted 3-(2-(1H-indol-1-yl)ethyl)-1H-indoles and 1,2-di(1H-indol-1-yl)alkanes as selective inhibitors of CDK4/cyclin D1. The compounds were designed to explore the relat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3202648fcc8e68bbedcdb54ed03e86a7
Flavonoids constitute a large class of polyphenolic compounds with cancer preventative properties. We have examined the ability of the natural flavone diosmetin to inhibit proliferation of breast adenocarcinoma MDA-MB 468 and normal breast MCF-10A ce
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e98e58b11e2984bc0893ec991356c9d0
http://hdl.handle.net/2086/2788
http://hdl.handle.net/2086/2788
Autor:
Bhabatosh Chaudhuri, Paul R. Jenkins, A. James Wilson, Sachin Mahale, Daniel P. G. Emmerson, Marcos D. García
Publikováno v:
ChemInform. 38
Autor:
A. James Wilson, Marcos D. García, Bhabatosh Chaudhuri, Daniel P. G. Emmerson, Paul R. Jenkins, Sachin Mahale
Publikováno v:
Organicbiomolecular chemistry. 4(24)
The design, synthesis and biological activity of a series of non-planar dihydro-beta-carboline and beta-carboline-based derivatives of the toxic anticancer agent fascaplysin is presented. We show these compounds to be selective inhibitors of CDK4 ove
Autor:
Bhabatosh Chaudhuri, Sachin Mahale
Publikováno v:
Enzyme Inhibitors Series ISBN: 9780849337741
Enzyme Inhibitors Series
Enzyme Inhibitors Series
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::62f12a76c25ff872410d86b24f966f1c
https://doi.org/10.1201/9781420005400.ch6
https://doi.org/10.1201/9781420005400.ch6
Autor:
Sachin Mahale, Michael J. Sutcliffe, Bhabatosh Chaudhuri, Jean-Didier Maréchal, Paul R. Jenkins, Carine Aubry
Publikováno v:
Bioorganic chemistry. 34(5)
Tryptamine derivatives, a new structural class of cyclin dependent kinase 4 inhibitors, have been identified during extensive biological screening of synthetic molecules. The molecules were synthesized based on the structure of fascaplysin, which is
Autor:
Michael J. Sutcliffe, Sachin Mahale, Paul R. Jenkins, Bhabatosh Chaudhuri, Jean-Didier Maréchal, Carine Aubry, A. James Wilson
Publikováno v:
Bioorganicmedicinal chemistry letters. 16(16)
Tryptamine derivatives, non-planar and potentially less toxic analogues of the anti-cancer agent fascaplysin, have been synthesised. They specifically inhibit Cdk4-D1 vis a vis Cdk2-A but, unlike fascaplysin, do not bind or intercalate DNA. CA224 is